CAACB Fall Workshop
Application of Automation, Digitalization, and AI for Pathogen Safety | ...
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.
CBI provides integrated solutions to global health
CBI Activities
Collaboration
MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.
Education
MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.
Research
MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.
Upcoming Events
October 2023
December 2023
2023 BioMAN Summit
Controlling Quality for Cell, Gene, and Complex Biologic Products
...
No event found!
Latest News & Research
Request for Proposals Announced
The Coca-Cola Company and CBI are pleased to announce a Grand Challenge to Provide Alternatives to Sugar. Please visit the…
FDA funds Center for Continuous mRNA Manufacturing
Researchers from MIT have received an award of $82 million over 3 years from the Food & Drug Administration (FDA)…
CAACB Publishes on NGS
The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) collected historical data from 20 biopharmaceutical industry members on their experience…
Our Team
CBI’s core strength is in our team’s cross-cutting experience and expertise in medicine, biology, chemistry, biomanufacturing, academic & clinical research, economics, engineering, data analytics, regulatory science and public policy.
Our Members
Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.
